ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0252

Capillaroscopic Signatures in Autoimmune Rheumatic Diseases: Unveiling Patterns in Systemic Sclerosis, Polyautoimmunity, and PAH

María Paula Carrillo1, Juan Esteban Bedoya-Loaiza1, Claudia Ibáñez-Antequera1, Laura Gallego1, Alejandro Escobar1, Adriana Rojas-Villarraga2 and Jairo Cajamarca-Baron3, 1Fundacion universitaria de ciencias de la salud, Bogota, Distrito Capital de Bogota, Colombia, 2Fundacion Universitaria de Ciencias de la salud, Bogotá, Distrito Capital de Bogota, Colombia, 3Fundacion universitaria de ciencia de la Salud, Bogota, Distrito Capital de Bogota, Colombia

Meeting: ACR Convergence 2025

Keywords: Angiogenesis, Imaging, Miscellaneous Rheumatic and Inflammatory Diseases

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 26, 2025

Title: (0233–0279) Miscellaneous Rheumatic & Inflammatory Diseases Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Nailfold capillaroscopy is a fundamental tool in rheumatology for assessing capillary morphology, allowing the differentiation between primary and secondary Raynaud’s phenomenon, identifying risks associated with systemic sclerosis, and exploring vascular alterations in various autoimmune diseases. This study aimed to describe capillaroscopic patterns in a cohort of patients with autoimmune disorders.

Methods: A cross-sectional, observational, and descriptive study was conducted in 136 patients with autoimmune rheumatic diseases. Sociodemographic, clinical, and capillaroscopic data were collected using the RedCap platform; images were obtained with the Smart G-Scope device and processed using Capillary.io software. Statistical analysis was performed using STATA 18.

Results: The cohort included 136 patients, mostly women (86.76%), with a median age of 59 years. Systemic sclerosis was the most prevalent disease (50.74%), followed by Sjögren’s syndrome and systemic lupus erythematosus; 24.2% presented with polyautoimmunity. Pulmonary arterial hypertension (PAH), confirmed or suspected, was found in 25 patients (18.3%). Capillary dilations (91.91%), giant capillaries (51.47%), and decreased capillary density (41.98%) were documented, particularly in systemic sclerosis. Microhemorrhages were observed in 58.82% of patients, most frequently in those with systemic sclerosis (49 out of 69 patients, 71.01%), followed by inflammatory myopathy (3 out of 5 patients, 60%) and Sjögren’s syndrome (16 out of 29 patients, 55.17%). Tortuosity was the most frequent morphological abnormality (26.47%) (See Table). In inflammatory myopathy, all patients exhibited at least one type of abnormal capillary morphology, with arborized capillaries being the most common. Systemic sclerosis, in turn, showed the greatest diversity and number of abnormal capillary forms. The most frequently observed pattern was nonspecific, followed by the active pattern in systemic sclerosis and inflammatory myopathies. The nonspecific pattern (n=50, 36.76%) was the most common overall, prevalent in all diseases except systemic sclerosis and inflammatory myopathy, where the active pattern predominated (n=27, 39.13% and n=3, 60%, respectively), reflecting greater microvascular aggressiveness in these conditions. Patients with positive ANAs had reduced capillary density (Fisher’s exact = 0.018), as did those with polyautoimmunity (p = 0.043), who also showed a higher number of microhemorrhages per millimeter (p = 0.020). Patients with PAH exhibited a higher number of capillary dilations per millimeter (p = 0.022) and reduced capillary density (≤6 capillaries/mm; p = 0.0444).

Conclusion: These findings support the use of videocapillaroscopy as a diagnostic and prognostic tool not only in systemic sclerosis but also in broader autoimmune contexts like polyautoimmunity and PAH.

Supporting image 1Summary of the frequencies of the most relevant capillaroscopic findings in autoimmune diseases


Disclosures: M. Carrillo: None; J. Bedoya-Loaiza: None; C. Ibáñez-Antequera: None; L. Gallego: None; A. Escobar: None; A. Rojas-Villarraga: None; J. Cajamarca-Baron: None.

To cite this abstract in AMA style:

Carrillo M, Bedoya-Loaiza J, Ibáñez-Antequera C, Gallego L, Escobar A, Rojas-Villarraga A, Cajamarca-Baron J. Capillaroscopic Signatures in Autoimmune Rheumatic Diseases: Unveiling Patterns in Systemic Sclerosis, Polyautoimmunity, and PAH [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/capillaroscopic-signatures-in-autoimmune-rheumatic-diseases-unveiling-patterns-in-systemic-sclerosis-polyautoimmunity-and-pah/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/capillaroscopic-signatures-in-autoimmune-rheumatic-diseases-unveiling-patterns-in-systemic-sclerosis-polyautoimmunity-and-pah/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology